Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors. Read more about Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.
Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab. Read more about Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab.
Systemic immune system alterations in early stages of Alzheimer's disease. Read more about Systemic immune system alterations in early stages of Alzheimer's disease.
Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). Read more about Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS).
Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). Read more about Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS).
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). Read more about MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). Read more about Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).
Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis. Read more about Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis.
No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. Read more about No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis. Read more about CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
